FDA approves 1st app to treat substance use disorders

The U.S. Food and Drug Administration has permitted the startup Pear Therapeutics to market the first medical app aiding in the treatment of substance use disorders, the agency announced Sept. 14. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link's validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org